ARROWHEAD PHARMACEUTICALS, INC. Increase (Decrease) in Prepaid Expense and Other Assets
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) reported Increase (Decrease) in Prepaid Expense and Other Assets of $29.94 million for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-04
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $21.53M, a 1431.08% increase year-over-year.
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$4.77M, a 123.44% decline year-over-year.
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $13.18M, a 2126.69% increase year-over-year.
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$12.40M.
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $9.94M, a 497.30% increase from fiscal 2024.
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $1.66M.
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$11.60M, a 160.15% decline from fiscal 2022.
- ARROWHEAD PHARMACEUTICALS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $19.29M, a 5258.61% increase from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $21.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-04 | $16.76M derived: sum of 2 quarters · filed 2026-08-04 | $29.94M 10-Q · filed 2026-08-04 | $17.54M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | -$4.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-07 | $8.41M 10-Q · filed 2026-05-07 | -$3.99M derived: sum of 3 quarters · filed 2026-05-07 | -$2.58M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | $13.18M 10-Q · filed 2026-02-05 | $779.00K derived: sum of 2 quarters · filed 2026-02-05 | $2.19M derived: sum of 3 quarters · filed 2026-08-04 | $22.53M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-09-30 | -$12.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | -$11.00M derived: sum of 2 quarters · filed 2026-08-04 | $9.35M derived: sum of 3 quarters · filed 2026-08-04 | $9.94M 10-K · filed 2025-11-25 | ||||
| 2025-06-30 | $1.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-04 | $21.75M derived: sum of 2 quarters · filed 2026-08-04 | $22.34M 10-Q · filed 2026-08-04 | $22.26M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | $20.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-07 | $20.94M 10-Q · filed 2026-05-07 | $20.85M derived: sum of 3 quarters · filed 2026-05-07 | $19.96M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $592.00K 10-Q · filed 2026-02-05 | $510.00K derived: sum of 2 quarters · filed 2026-02-05 | -$387.00K derived: sum of 3 quarters · filed 2026-02-05 | $508.00K derived: sum of 4 quarters · filed 2026-02-05 | ||||
| 2024-09-30 | -$82.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | -$979.00K derived: sum of 2 quarters · filed 2025-11-25 | -$84.00K derived: sum of 3 quarters · filed 2025-11-25 | $1.66M 10-K · filed 2025-11-25 | ||||
| 2024-06-30 | -$897.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-07 | -$2.00K derived: sum of 2 quarters · filed 2025-08-07 | $1.75M 10-Q · filed 2025-08-07 | $18.06M derived: sum of 4 quarters · filed 2025-11-25 | ||||
| 2024-03-31 | $895.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-12 | $2.64M 10-Q · filed 2025-05-12 | $18.95M derived: sum of 3 quarters · filed 2025-11-25 | $11.35M derived: sum of 4 quarters · filed 2025-11-25 | ||||
| 2023-12-31 | $1.75M 10-Q · filed 2025-02-10 | $18.06M derived: sum of 2 quarters · filed 2025-11-25 | $10.45M derived: sum of 3 quarters · filed 2025-11-25 | $674.00K derived: sum of 4 quarters · filed 2025-11-25 | ||||
| 2023-09-30 | $16.31M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $8.71M derived: sum of 2 quarters · filed 2025-11-25 | -$1.07M derived: sum of 3 quarters · filed 2025-11-25 | -$11.60M 10-K · filed 2025-11-25 | ||||
| 2023-06-30 | -$7.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-08 | -$17.38M derived: sum of 2 quarters · filed 2024-08-08 | -$27.91M 10-Q · filed 2024-08-08 | -$17.49M derived: sum of 4 quarters · filed 2024-11-26 | ||||
| 2023-03-31 | -$9.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-09 | -$20.31M 10-Q · filed 2024-05-09 | -$9.88M derived: sum of 3 quarters · filed 2024-11-26 | -$4.33M derived: sum of 4 quarters · filed 2024-11-26 | ||||
| 2022-12-31 | -$10.53M 10-Q · filed 2024-02-06 | -$105.00K derived: sum of 2 quarters · filed 2024-11-26 | $5.45M derived: sum of 3 quarters · filed 2024-11-26 | $8.31M derived: sum of 4 quarters · filed 2024-11-26 | ||||
| 2022-09-30 | $10.42M derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-26 | $15.98M derived: sum of 2 quarters · filed 2024-11-26 | $18.84M derived: sum of 3 quarters · filed 2024-11-26 | $19.29M 10-K · filed 2024-11-26 | ||||
| 2022-06-30 | $5.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-07 | $8.42M derived: sum of 2 quarters · filed 2023-08-07 | $8.87M 10-Q · filed 2023-08-07 | $8.88M 10-Q · filed 2022-08-04 | $6.33M derived: sum of 4 quarters · filed 2023-11-29 | |||
| 2022-03-31 | $2.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-02 | $3.31M 10-Q · filed 2023-05-02 | $7.91M 10-Q · filed 2022-05-10 | $778.00K derived: sum of 3 quarters · filed 2023-11-29 | $1.46M derived: sum of 4 quarters · filed 2023-11-29 | |||
| 2021-12-31 | $450.00K 10-Q · filed 2023-02-06 | $1.18M 10-Q · filed 2022-02-02 | -$2.08M derived: sum of 2 quarters · filed 2023-11-29 | -$1.40M derived: sum of 3 quarters · filed 2023-11-29 | -$2.38M derived: sum of 4 quarters · filed 2023-11-29 | |||
| 2021-09-30 | -$2.54M derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-29 | -$1.85M derived: sum of 2 quarters · filed 2023-11-29 | -$2.83M derived: sum of 3 quarters · filed 2023-11-29 | $360.00K 10-K · filed 2023-11-29 | ||||
| 2021-06-30 | $682.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-04 | -$298.00K derived: sum of 2 quarters · filed 2022-08-04 | $2.90M 10-Q · filed 2022-08-04 | $2.42M derived: sum of 4 quarters · filed 2022-11-28 | ||||
| 2021-03-31 | -$980.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-10 | $2.21M 10-Q · filed 2022-05-10 | $1.74M derived: sum of 3 quarters · filed 2022-11-28 | $2.65M derived: sum of 4 quarters · filed 2022-11-28 | ||||
| 2020-12-31 | $3.19M 10-Q · filed 2022-02-02 | $2.72M derived: sum of 2 quarters · filed 2022-11-28 | $3.63M derived: sum of 3 quarters · filed 2022-11-28 | $4.96M derived: sum of 4 quarters · filed 2022-11-28 | ||||
| 2020-09-30 | -$476.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-28 | $434.00K derived: sum of 2 quarters · filed 2022-11-28 | $1.76M derived: sum of 3 quarters · filed 2022-11-28 | $387.00K 10-K · filed 2022-11-28 | $387.46K 10-K · filed 2020-11-23 | |||
| 2020-06-30 | $910.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-05 | $2.24M derived: sum of 2 quarters · filed 2021-08-05 | $863.00K 10-Q · filed 2021-08-05 | $863.29K 10-Q · filed 2020-08-05 | $2.18M derived: sum of 4 quarters · filed 2021-11-22 | |||
| 2020-03-31 | $1.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-04 | -$47.00K 10-Q · filed 2021-05-04 | -$46.52K 10-Q · filed 2020-05-07 | $1.27M derived: sum of 3 quarters · filed 2021-11-22 | $2.22M derived: sum of 4 quarters · filed 2021-11-22 | |||
| 2019-12-31 | -$1.38M 10-Q · filed 2021-02-04 | -$1.38M 10-Q · filed 2020-02-05 | -$60.23K derived: sum of 2 quarters · filed 2021-11-22 | $892.71K derived: sum of 3 quarters · filed 2021-11-22 | $2.21M derived: sum of 4 quarters · filed 2021-11-22 | |||
| 2019-09-30 | $1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-22 | $2.27M derived: sum of 2 quarters · filed 2021-11-22 | $3.59M derived: sum of 3 quarters · filed 2021-11-22 | $3.71M 10-K · filed 2021-11-22 | $3.71M 10-K · filed 2019-11-25 | |||
| 2019-06-30 | $952.94K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-05 | $2.27M derived: sum of 2 quarters · filed 2020-08-05 | $2.39M 10-Q · filed 2020-08-05 | $2.93M derived: sum of 4 quarters · filed 2020-11-23 | ||||
| 2019-03-31 | $1.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-07 | $1.44M 10-Q · filed 2020-05-07 | $1.98M derived: sum of 3 quarters · filed 2020-11-23 | $2.35M derived: sum of 4 quarters · filed 2020-11-23 | ||||
| 2018-12-31 | $120.91K 10-Q · filed 2020-02-05 | $658.00K derived: sum of 2 quarters · filed 2020-11-23 | $1.03M derived: sum of 3 quarters · filed 2020-11-23 | -$227.48K derived: sum of 4 quarters · filed 2020-11-23 | ||||
| 2018-09-30 | $537.09K derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-23 | $906.40K derived: sum of 2 quarters · filed 2020-11-23 | -$348.39K derived: sum of 3 quarters · filed 2020-11-23 | -$319.17K 10-K · filed 2020-11-23 | ||||
| 2018-06-30 | $369.31K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-05 | -$885.48K derived: sum of 2 quarters · filed 2019-08-05 | -$856.25K 10-Q · filed 2019-08-05 | -$494.21K derived: sum of 4 quarters · filed 2019-11-25 | ||||
| 2018-03-31 | -$1.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-08 | -$1.23M 10-Q · filed 2019-05-08 | -$863.52K derived: sum of 3 quarters · filed 2019-11-25 | -$1.52M derived: sum of 4 quarters · filed 2019-11-25 | ||||
| 2017-12-31 | $29.22K 10-Q · filed 2019-02-07 | $391.26K derived: sum of 2 quarters · filed 2019-11-25 | -$261.18K derived: sum of 3 quarters · filed 2019-11-25 | -$1.76M derived: sum of 4 quarters · filed 2019-11-25 | ||||
| 2017-09-30 | $362.04K derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-25 | -$290.40K derived: sum of 2 quarters · filed 2019-11-25 | -$1.79M derived: sum of 3 quarters · filed 2019-11-25 | -$2.81M 10-K · filed 2019-11-25 | ||||
| 2017-06-30 | -$652.44K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-07 | -$2.15M derived: sum of 2 quarters · filed 2018-08-07 | -$3.18M 10-Q · filed 2018-08-07 | -$3.04M derived: sum of 4 quarters · filed 2018-12-11 | ||||
| 2017-03-31 | -$1.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-08 | -$2.52M 10-Q · filed 2018-05-08 | -$2.39M derived: sum of 3 quarters · filed 2018-12-11 | -$2.12M derived: sum of 4 quarters · filed 2018-12-11 | ||||
| 2016-12-31 | -$1.03M 10-Q · filed 2018-02-09 | -$893.71K derived: sum of 2 quarters · filed 2018-12-11 | -$622.96K derived: sum of 3 quarters · filed 2018-12-11 | -$496.34K derived: sum of 4 quarters · filed 2018-12-11 | ||||
| 2016-09-30 | $133.31K derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-11 | $404.06K derived: sum of 2 quarters · filed 2018-12-11 | $530.68K derived: sum of 3 quarters · filed 2018-12-11 | $1.02M 10-K · filed 2018-12-11 | ||||
| 2016-06-30 | $270.75K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-03 | $397.37K derived: sum of 2 quarters · filed 2017-08-03 | $887.43K 10-Q · filed 2017-08-03 | $850.08K derived: sum of 4 quarters · filed 2017-12-12 | ||||
| 2016-03-31 | $126.62K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-03 | $616.68K 10-Q · filed 2017-05-03 | $641.84K 10-Q · filed 2016-05-10 | $579.34K derived: sum of 3 quarters · filed 2017-12-12 | $599.48K derived: sum of 4 quarters · filed 2017-12-12 | |||
| 2015-12-31 | $490.06K 10-Q · filed 2017-02-06 | $452.71K derived: sum of 2 quarters · filed 2017-12-12 | $472.86K derived: sum of 3 quarters · filed 2017-12-12 | |||||
| 2015-09-30 | -$37.34K derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-12 | -$17.20K derived: sum of 2 quarters · filed 2017-12-12 | $3.49M 10-K · filed 2017-12-12 | |||||
| 2015-06-30 | $20.14K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-09 | $3.52M 10-Q · filed 2016-08-09 | ||||||
| 2015-03-31 | $3.50M 10-Q · filed 2016-05-10 | |||||||
| 2014-09-30 | $54.97K 10-K · filed 2016-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |